Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2016 June;28(2) > Minerva Biotecnologica 2016 June;28(2):114-9

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

MINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,25


eTOC

 

ORIGINAL ARTICLES  FREEfree


Minerva Biotecnologica 2016 June;28(2):114-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Pycnogenol® reduces the wheal and flare response to histamine in normal subjects

Gianni BELCARO, Beatrice FERAGALLI, Morio HOSOI, Mark DUGALL, Umberto CORNELLI

Irvine3 Circulation Vascular Labs, Ch-Pe University, Spoltore, Pescara, Italy


FULL TEXT  


BACKGROUND: The aim of this study was the evaluation of the action of the sup­plementation with Pycnogenol® on the wheal and flare (after local histamine injection) evolution in healthy individuals in association with the evaluation of capillary per­meability (CF) with straingauge plethysmography.
METHODS: A control group a group using Pycnogenol® (100 mg/day) and a group using 150 mg/day (for 3 days) were studied. A microinjection of histamine generates a wheal and flare response that was evaluated for flux, redness, thickness and persistence. The 3 groups were comparable.
RESULTS: The variations in flux (laser Doppler) from time zero to 160 minutes indicated that flux was more elevated in controls with a proportional reduction, dose-related in the Pycnogenol® groups. The higher dose of Pycnogenol reduced the wheal and flare response (p<0.05) in comparison with the lower dose. The peak flux – the ‘redness’ surrounding the injection point - was at about 37 minutes in controls and it was delayed in Pycnogenol® groups (about 50 minutes; p<0.05). The wheal areas, the redness (scale 0 to 3), the time for complete disappearance of the wheal and ultrasound skin thickness were decreased with Pycnogenol® (p<0.05) with a significant difference between the two doses). Variations in distal ankle CF (straingauge) were minimal (it must be considered that initial values were normal with minimal possibility of changes).
CONCLUSIONS: These results indicate that Pycnogenol® has a significant, preminent local action in controlling histamine reactions. In conclusion, this evaluation indicates a significant, local, anti-histamine action of Pycnogenol. These pre­liminary observations suggest potential applications of the extract from French Pine Bark for supplementation in the prevention of allergic conditions or in pre-clinical risk situations in subjects at risk of histamine-related conditions and in some patients with significant conditions (asthma, skin allergic reactions) often associated to increased capillary permeability and edema.

inizio pagina

Publication History

Per citare questo articolo

Belcaro G, Feragalli B, Hosoi M, Dugall M, Cornelli U. Pycnogenol® reduces the wheal and flare response to histamine in normal subjects. Minerva Biotec 2016 June;28(2):114-9. 

Corresponding author e-mail